Khati Nadia, Adamson Tammy, Johnson Karen S, Hill Michael C
Department of Radiology, The George Washington University, Washington, DC 20037, USA.
Ultrasound Q. 2003 Dec;19(4):162-76. doi: 10.1097/00013644-200312000-00002.
Ultrasound plays a prominent role in the management of thyroid disease and parathyroid adenomas. It can detect clinically impalpable thyroid nodules and characterize them as cystic, solid, or complex. Determining that a nodule is definitively benign or malignant is difficult, and so when indicated an ultrasound-guided fine-needle aspiration can be performed. In the follow-up of patients with thyroid cancer, ultrasound can be used alone or in conjunction with computed tomography (CT)/magnetic resonance imaging (MRI) to detect recurrent disease. Recurrences can be confirmed using ultrasound to guide fine-needle aspirations. To locate parathyroid adenomas, ultrasound is often used in conjunction with sestamibi scanning. If both studies agree on the location of the adenoma, the surgeon can perform focused surgery for its removal. In patients in whom the studies do not agree or in whom they do not detect the adenoma, further evaluation with CT or more preferably MRI is indicated.
超声在甲状腺疾病和甲状旁腺腺瘤的管理中发挥着重要作用。它可以检测出临床上无法触及的甲状腺结节,并将其特征描述为囊性、实性或混合性。确定一个结节是明确良性还是恶性很困难,因此在有指征时可进行超声引导下细针穿刺抽吸。在甲状腺癌患者的随访中,超声可单独使用或与计算机断层扫描(CT)/磁共振成像(MRI)联合使用以检测复发疾病。复发可通过超声引导细针穿刺抽吸来确诊。为了定位甲状旁腺腺瘤,超声常与锝[99mTc]甲氧基异丁基异腈(sestamibi)扫描联合使用。如果两项检查对腺瘤的位置一致,外科医生可以进行针对性手术切除。对于两项检查结果不一致或未检测到腺瘤的患者,则需要进一步进行CT评估,更优选MRI评估。